血清脑损伤生物标志物对儿童复苏后神经学结局分类的预后价值
该回顾性研究纳入95例在儿科心脏重症监护室心脏骤停后治疗的儿童,检测神经元特异性烯醇化酶和S100b蛋白,用儿科脑功能分类量表评估出院时神经学结局,不良结局定义为较骤停前状态变化>1或死亡。58例(61.1%)存活出院,48例(50.5%)神经学结局良好。不良结局组在指定时间点两种标志物均显著升高(神经元特异性烯醇化酶在骤停后24、48、72小时,S100b在12、24、48小时,P<0.05)。神经元特异性烯醇化酶24小时曲线下面积0.83,多变量分析中为不良结局的独立预测因子。作者认为两种标志物可分类不良神经学结局,但需进一步多机构前瞻性研究确定儿童可靠截断值。
要点
- 95例儿科心脏骤停后患儿中,58例(61.1%)存活出院,48例(50.5%)神经学结局良好。
- 不良结局组神经元特异性烯醇化酶在骤停后24、48、72小时显著高于良好结局组(P<0.05)。
- 不良结局组S100b在骤停后12、24、48小时显著高于良好结局组(P<0.05)。
- 神经元特异性烯醇化酶24小时曲线下面积0.83,多变量分析中为不良结局的独立预测因子。
- S100b 12小时曲线下面积0.87,24小时0.81,48小时0.82。
适用人群与场景
- 在儿科心脏重症监护室心脏骤停后治疗的95例儿童。
诊断标准与关键阈值
- 神经学结局于出院时用儿科脑功能分类量表评估,不良结局定义为较骤停前状态变化>1或死亡。
研究设计与关键结果
- 回顾性研究,95例儿科心脏骤停后患儿,检测神经元特异性烯醇化酶和S100b,评估出院时神经学结局。
- 58例(61.1%)存活出院,48例(50.5%)神经学结局良好。
- 不良结局组神经元特异性烯醇化酶在骤停后24、48、72小时显著升高(P<0.05),S100b在12、24、48小时显著升高(P<0.05)。
- 神经元特异性烯醇化酶曲线下面积:24小时0.83,48小时0.80,72小时0.73;S100b曲线下面积:12小时0.87,24小时0.81,48小时0.82。
- 多变量分析中,骤停后24小时神经元特异性烯醇化酶为不良结局的独立预测因子。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性;作者在结论中提出需进一步多机构前瞻性研究以全面评估这些标志物在不同临床条件下的诊断准确性并确定儿童可靠截断值。
对床旁实践的改变
- 作者认为神经元特异性烯醇化酶和S100b可在此大型儿科心脏骤停队列中分类不良神经学结局。
- 作者建议需进一步多机构前瞻性研究,以全面评估这些标志物在不同临床条件下的诊断准确性并确定儿童可靠截断值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To investigate if the serum biomarkers of cerebral injury, neuron-specific enolase and S100b protein, may classify unfavourable neurological outcome after paediatric cardiac arrest.
METHODS: We performed a retrospective study of neuron-specific enolase and S100b measurements from 95 children treated in our paediatric cardiac intensive care unit after cardiac arrest. Neurological outcome at discharge was evaluated using the paediatric cerebral performance category scale, with unfavourable outcome defined as a change of >1 compared to pre-arrest status or death.
RESULTS: Fifty-eight patients (61.1%) survived to discharge with 48 (50.5%) having a favourable neurological outcome. We observed significantly higher levels of both biomarkers in the unfavourable outcome group at designated time points (neuron-specific enolase at 24, 48, and 72h and S100b at 12, 24, and 48h after cardiac arrest, p<0.05). Receiver operating characteristic areas under the curve for neuron-specific enolase were 0.83, 0.80, and 0.73 at time points 24, 48, and 72h and 0.87, 0.81, and 0.82 for S100b at 12, 24, and 48h after cardiac arrest, respectively. Neuron-specific enolase measurement at 24h after cardiac arrest was an independent predictor of unfavourable outcome in a multivariable analysis.
CONCLUSIONS: Neuron-specific enolase and S100b classify unfavourable neurological outcome in this large paediatric cardiac arrest cohort. Further multi-institutional prospective studies to comprehensively evaluate the diagnostic accuracy of these biomarkers under various clinical conditions and to determine reliable cut-off values in children are warranted.
参考来源
- Kramer P, Miera O, Berger F, et al. Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation. Resuscitation. 2017. PMID: 28939504. doi:10.1016/j.resuscitation.2017.09.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。